Navigation Links
Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad

Chandler, AZ (PRWEB) June 27, 2012

360 Vantage®, a leader in cloud-based sales and marketing technology solutions for the Life Sciences industry, announced today its agreement with a specialty pharmaceutical company in the aesthetics market for its closed loop marketing app (360 CLM™) for the Apple® iPad®.

Under the agreement, 360 Vantage delivered its 360 CLM app as a cloud-based service by which the company’s sales forces can now present approved marketing materials directly to prescribers via the Apple iPad. The tailored CLM system helps streamline the client’s requirements for wireless content delivery, management and retraction of digital marketing assets including visual aids, package inserts, formulary data, demonstration videos and reprints.

With the 360 CLM system in place, sales reps are more responsive to individual prescriber needs. The company’s marketing department also gets instant feedback on asset usage while maintaining strict compliance guidelines and reducing print production costs in the process.

The 360 CLM system was deployed to the company’s sales reps, giving them the ability to instantly view and push approved content via email to a specific customer. The system also provides territory, regional and national level metrics for all assets in the system, helping marketing and management track detailed usage of the assets through the report and dashboard engine so they can determine the effectiveness of each asset.

About 360 Vantage®
Established in 2005 and headquartered in Chandler, Arizona, 360 Vantage® is a leader in cloud-based mobile sales and marketing systems designed to solve the more complex front office challenges in Life Sciences, Healthcare and other industries. The company offers a full suite of professional and managed services in addition to its 360 CRM™, 360 CLM™, e-Learning and compliance solutions. Built on the platform and, systems are designed to empower the mobile sales force an marketing teams with anytime, anywhere access to customer data and sales aids – from any device – giving the organization a distinct competitive advantage. The company CEO and founder, Mario Martinez II, is a Life Sciences sales and marketing technology veteran and can be found on the company blog, Twitter @360Vantage or @360CEO, LinkedIn, Google+ and Facebook. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
4. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
5. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
6. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
7. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
8. The respective roles of the public and private sectors in pharmaceutical innovation
9. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
10. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
11. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
Post Your Comments:
(Date:10/13/2015)... -- Cepheid (Nasdaq: CPHD ) today announced preliminary results ... --> --> Based on Cepheid,s ... of 2015 is expected to be approximately $126.5 million, ... approximately $(0.32) for the third quarter.  Based on Cepheid,s ... the third quarter of 2015 is expected to be ...
(Date:10/13/2015)... , Oct. 13, 2015 Applied BioMath ( ... critical decision points throughout the drug invention process, announced ... Boston 2015 on October 20-22, 2015 in ... PhD, Co-Founder, President, and CEO of Applied BioMath, will ... early research to clinical trials" on Wednesday October 21st ...
(Date:10/13/2015)... October 13, 2015      Q ... company, has entered into a strategic relationship with Wombat ... and Paris, France based strategic ... --> This collaborative arrangement gives Q BioMed ... advisory team as well as long established pharmaceutical industry ...
(Date:10/13/2015)... CA (PRWEB) , ... October 13, 2015 , ... Clinovo ... key expertise to the company’s fast growing clinical data solutions business. , Jeff Parr ... science companies of all sizes, including Avery Dennison, Thermo Fisher, and Ab Sciex to ...
Breaking Biology Technology:
(Date:10/9/2015)... ) ... "Samsung Galaxy S6 Fingerprint Sensor - Reverse ... --> ) has announced ... S6 Fingerprint Sensor - Reverse Costing Analysis" ... Research and Markets ( ) ...
(Date:10/8/2015)... , October 8, 2015 ... the "Company"), a biometric authentication company focused on ... the Wocket® smart wallet announces that revenues for ... approximately $410,000 compared with $113,00 for the three ... 9 months ended September 30, 2015 were approximately ...
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, Inc. ... that it has signed a contract with the Virginia ... the full range of sentences under the Department,s oversight. ... the Americas. "This contract with the Virginia DOC will ... US and advances our position as a trusted leader ...
Breaking Biology News(10 mins):